U.S. market Open. Closes in 6 hours 11 minutes

PCSA | Processa Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A5.00K113.42K200.20K312.48K192.15K20.00K140.00K
Cost of Revenue222.0027.53M12.13M15.14M877.90KN/AN/AN/A125.88K113.25K188.00K133.25KN/A150.00K
Gross Profit-222.00-27.53M-12.13M-15.14M-877.90KN/AN/A5.00K-12.45K86.95K124.48K58.89K20.00K-10.00K
Operating Expenses11.46M20.26M11.57M6.44M3.94M4.52M1.80M76.53K974.71K3.03M3.09M2.33M790.00K150.00K
Selling, General & Admin5.66M8.76M4.69M3.26M1.61M1.44M876.32K139.94K1.89MN/AN/AN/A610.00K40.00K
Research & Development5.80M11.49M6.88M3.17M2.32M3.09M926.12K6.56K29.25K189.75K267.06K448.03K170.00K110.00K
Other Operating Expenses0N/AN/AN/AN/AN/AN/A-69.97K-945.46K2.84M2.82M1.88M10.00KN/A
Operating Income-11.46M-27.53M-12.13M-15.14M-3.94M-4.52M-1.80M-71.53K-987.16K-2.95M-2.96M-2.27M-770.00K-160.00K
Other Expenses / Income335.54K101.20K175.40K-277.95K-25.11K-142.91K-53.88K-265.65K-2.00M-1.58M-107.33K-167.58K-170.00KN/A
Before Tax Income-11.12M-27.42M-11.96M-15.41M-3.96M-4.67M-1.86M-337.18K-2.98M-4.53M-3.07M-2.44M-940.00K-160.00K
Income Tax Expenses-2.0027.42M-530.61K-1.00M-602.72K-902.80KN/AN/A100.00100.0050.00181.00N/AN/A
Net Income-11.12M-54.85M-11.43M-14.41M-3.36M-3.77M-1.86M-335.98K-3.35M-4.53M-3.07M-2.44M-940.00K-160.00K
Interest ExpensesN/A-101.20K362.00281.12K36.66K161.21K35.69K245.38K235.64K365.96K109.72K170.72K-170.00KN/A
Basic Shares Outstanding13.12M16.11M15.32M7.50M276.28K5.33M4.66M224.84K224.75K180.77K102.80K201.22K920.00K920.00K
Diluted Shares Outstanding13.12M16.11M15.32M7.50M276.28K5.33M4.66M224.84K224.75K180.77K102.80K201.22K920.00K920.00K
EBITDA-11.46M-12.20M-10.76M-5.63M-3.12M-3.88M-1.82M-90.44K-2.88M-3.70M-2.54M-2.16M-1.11M-160.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,808.78%-2,538.82%-1,847.61%-814.14%-1,124.76%-5,550.00%-114.29%
EBIT-11.12M-27.53M-11.96M-15.13M-3.92M-4.51M-1.82M-90.60K-3.12M-4.16M-2.96M-2.27M-1.11M-160.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,811.96%-2,749.38%-2,078.01%-946.92%-1,181.21%-5,550.00%-114.29%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙